LB Pharmaceuticals Inc. terminated employment of Dr. Anna Eramo effective June 15, 2026, with severance payments through September 2026 and potential extension through June 2027 pending consulting agreement compliance. The executive separation includes base salary continuation and a prorated bonus payment, representing a standard leadership transition.